ADA Scientific Sessions 2025 Abstract

Glycemic Outcomes When Switching to iGlarLixi from Premixed Insulin (PI) in People with Type 2 Diabetes (T2D) by iGlarLixi Pen Subgroups—Post Hoc Analysis of Soli-SWITCH

By Martin Haluzík, Felipe Lauand, Soraly Servera, Ramazan Sari

Trial in peopleInterventions

The paper

Martin Haluzík, Felipe Lauand, Soraly Servera, Ramazan Sari

Prague

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, poster 806-P

doi.org/10.2337/db25-806-p

Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity